Interpace Diagnostics Group, Inc.
Interpace Diagnostics Group, Inc. (IDGX) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 8 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Mar 10, 2021 involved a transaction of 50,000 shares valued at $0.
IDGX Insider Activity Summary
Who Is Buying IDGX Stock?
No significant insider buying has been recorded for IDGX in the recent period.
Who Is Selling IDGX Stock?
No significant insider selling has been recorded for IDGX in the recent period.
Is Interpace Diagnostics Group, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for IDGX is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
IDGX Frequently Asked Questions
Understanding IDGX Insider Activity
Insider trading at Interpace Diagnostics Group, Inc. (IDGX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading IDGX stock, having executed 8 transactions in the past 90 days. The most active insider is Thomas John Freeburg (Executive), who has made 2 transactions totaling $0.
Related Tools
Track Interpace Diagnostics Group, Inc. Insider Activity
Get notified when executives and directors at IDGX file new Form 4 transactions